Effects of diethylstilbestrol (DES) medication during pregnancy: report from a symposium at the 10th international congress of ISPOG
| Autor: | Cabau A, Buitendijk S, Palmlund I, Forsberg Jg, Apfel R |
|---|---|
| Přispěvatelé: | Other departments |
| Jazyk: | angličtina |
| Rok vydání: | 1993 |
| Předmět: |
medicine.medical_specialty
medicine.drug_class education Diethylstilbestrol Uterine Cervical Neoplasms Adenocarcinoma Pregnancy Risk Factors International congress medicine Humans Practice Patterns Physicians' Developing Countries health care economics and organizations Gynecology business.industry Reproductive life Abnormalities Drug-Induced Obstetrics and Gynecology Pregnancy Report medicine.disease Drug Utilization United States humanities Europe Pregnancy Complications Psychiatry and Mental health Clinical Psychology Reproductive Medicine Estrogen Gestation Female business medicine.drug |
| Zdroj: | Journal of psychosomatic obstetrics and gynaecology, 14(1), 71-89. Informa Healthcare |
| ISSN: | 0167-482X |
| Popis: | This article is a report based on presentations at the symposium Effects of Diethylstilbestrol (DES) Medication during Pregnancy at the conference Reproductive Life, 10th International Congress of The International Society of Psychosomatic Obstetrics and Gynaecology (ISPOG) in Stockholm, Sweden June 14-17, 1992. The objective of this symposium, chaired by Eylard van Hall and Ingar Palmlund, was to provide the basis for a discussion of how the risks of DES had been evaluated in different countries. In the general discussion following the presentations everybody present expressed concerns that DES might still be given to pregnant women in many parts of the world, called for measures to alert medical professionals world-wide to the hazards of the use of DES, and requested measures to effect an international ban of DES in medication for pregnant women. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|